182 related articles for article (PubMed ID: 8995719)
1. Role of interleukin-6 in mediating mesangial cell proliferation and matrix production in vivo.
Eitner F; Westerhuis R; Burg M; Weinhold B; Gröne HJ; Ostendorf T; Rüther U; Koch KM; Rees AJ; Floege J
Kidney Int; 1997 Jan; 51(1):69-78. PubMed ID: 8995719
[TBL] [Abstract][Full Text] [Related]
2. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis.
Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ
Am J Pathol; 1997 Jul; 151(1):141-50. PubMed ID: 9212740
[TBL] [Abstract][Full Text] [Related]
3. Modulation of experimental mesangial proliferative nephritis by interferon-gamma.
Johnson RJ; Lombardi D; Eng E; Gordon K; Alpers CE; Pritzl P; Floege J; Young B; Pippin J; Couser WG
Kidney Int; 1995 Jan; 47(1):62-9. PubMed ID: 7731171
[TBL] [Abstract][Full Text] [Related]
4. C-type natriuretic peptide inhibits mesangial cell proliferation and matrix accumulation in vivo.
Canaan-Kühl S; Ostendorf T; Zander K; Koch KM; Floege J
Kidney Int; 1998 May; 53(5):1143-51. PubMed ID: 9573528
[TBL] [Abstract][Full Text] [Related]
5. Laser capture microdissection and real-time PCR for analysis of glomerular endothelin-1 gene expression in mesangiolysis of rat anti-Thy 1.1 and murine Habu Snake Venom glomerulonephritis.
Dimmler A; Haas CS; Cho S; Hattler M; Forster C; Peters H; Schöcklmann HO; Amann K
Diagn Mol Pathol; 2003 Jun; 12(2):108-17. PubMed ID: 12766616
[TBL] [Abstract][Full Text] [Related]
6. Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis.
Floege J; Eng E; Young BA; Couser WG; Johnson RJ
Kidney Int; 1993 Feb; 43(2):369-80. PubMed ID: 8441232
[TBL] [Abstract][Full Text] [Related]
7. De novo CD44 expression by proliferating mesangial cells in rat anti-Thy-1 nephritis.
Nikolic-Paterson DJ; Jun Z; Tesch GH; Lan HY; Foti R; Atkins RC
J Am Soc Nephrol; 1996 Jul; 7(7):1006-14. PubMed ID: 8829115
[TBL] [Abstract][Full Text] [Related]
8. P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
Rost S; Daniel C; Schulze-Lohoff E; Bäumert HG; Lambrecht G; Hugo C
Kidney Int; 2002 Nov; 62(5):1659-71. PubMed ID: 12371966
[TBL] [Abstract][Full Text] [Related]
9. Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats.
Floege J; Eng E; Young BA; Alpers CE; Barrett TB; Bowen-Pope DF; Johnson RJ
J Clin Invest; 1993 Dec; 92(6):2952-62. PubMed ID: 7902849
[TBL] [Abstract][Full Text] [Related]
10. Signal transduction involved in protective effects of 15(R/S)-methyl- lipoxin A(4) on mesangioproliferative nephritis in rats.
Wu SH; Wu XH; Liao PY; Dong L
Prostaglandins Leukot Essent Fatty Acids; 2007 Mar; 76(3):173-80. PubMed ID: 17329090
[TBL] [Abstract][Full Text] [Related]
11. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
Chen YM; Chien CT; Hu-Tsai MI; Wu KD; Tsai CC; Wu MS; Tsai TJ
Kidney Int; 1999 Sep; 56(3):932-43. PubMed ID: 10469361
[TBL] [Abstract][Full Text] [Related]
12. In situ hybridization in the study of remodeling in proliferative glomerulonephritis.
Barnes JL
Toxicol Pathol; 1998; 26(1):43-51. PubMed ID: 9502386
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-10 inhibits experimental mesangial proliferative glomerulonephritis.
Kitching AR; Katerelos M; Mudge SJ; Tipping PG; Power DA; Holdsworth SR
Clin Exp Immunol; 2002 Apr; 128(1):36-43. PubMed ID: 11982588
[TBL] [Abstract][Full Text] [Related]
14. Alpha8 integrin in glomerular mesangial cells and in experimental glomerulonephritis.
Hartner A; Schöcklmann H; Pröls F; Müller U; Sterzel RB
Kidney Int; 1999 Oct; 56(4):1468-80. PubMed ID: 10504498
[TBL] [Abstract][Full Text] [Related]
15. In vitro effects of Habu snake venom on cultured mesangial cells.
Kubo A; Iwano M; Kobayashi Y; Kyoda Y; Isumi Y; Maruyama N; Samejima K; Dohi Y; Minamino N; Yonemasu K
Nephron; 2002; 92(3):665-72. PubMed ID: 12372952
[TBL] [Abstract][Full Text] [Related]
16. Treatment of experimental mesangioproliferative glomerulonephritis with non-anticoagulant heparin: therapeutic efficacy and safety.
Burg M; Ostendorf T; Mooney A; Koch KM; Floege J
Lab Invest; 1997 Apr; 76(4):505-16. PubMed ID: 9111513
[TBL] [Abstract][Full Text] [Related]
17. Tenascin-C promotes healing of Habu-snake venom-induced glomerulonephritis: studies in knockout congenic mice and in culture.
Nakao N; Hiraiwa N; Yoshiki A; Ike F; Kusakabe M
Am J Pathol; 1998 May; 152(5):1237-45. PubMed ID: 9588892
[TBL] [Abstract][Full Text] [Related]
18. Rat glomerular mesangial cells synthesize basic fibroblast growth factor. Release, upregulated synthesis, and mitogenicity in mesangial proliferative glomerulonephritis.
Floege J; Eng E; Lindner V; Alpers CE; Young BA; Reidy MA; Johnson RJ
J Clin Invest; 1992 Dec; 90(6):2362-9. PubMed ID: 1361494
[TBL] [Abstract][Full Text] [Related]
19. A fully human monoclonal antibody (CR002) identifies PDGF-D as a novel mediator of mesangioproliferative glomerulonephritis.
Ostendorf T; van Roeyen CR; Peterson JD; Kunter U; Eitner F; Hamad AJ; Chan G; Jia XC; Macaluso J; Gazit-Bornstein G; Keyt BA; Lichenstein HS; LaRochelle WJ; Floege J
J Am Soc Nephrol; 2003 Sep; 14(9):2237-47. PubMed ID: 12937299
[TBL] [Abstract][Full Text] [Related]
20. Extracellular actin impairs glomerular capillary repair in experimental mesangioproliferative glomerulonephritis.
Janssen U; Eitner F; Kunter U; Ostendorf T; Wolf G; Chaponnier C; Gabbiani G; Kerjaschki D; Floege J
Nephron Exp Nephrol; 2003; 93(4):e158-67. PubMed ID: 12759577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
